Literature DB >> 20152802

NMR characterization of intramolecular interaction of osteopontin, an intrinsically disordered protein with cryptic integrin-binding motifs.

Yoshiki Yamaguchi1, Shinya Hanashima, Hirokazu Yagi, Yutaka Takahashi, Hiroaki Sasakawa, Eiji Kurimoto, Takeshi Iguchi, Shigeyuki Kon, Toshimitsu Uede, Koichi Kato.   

Abstract

Osteopontin (OPN) is an integrin-binding protein found in a variety of tissues and physiological fluids and is involved in divergent biological processes such as migration, adhesion and signaling in integrin-independent as well as dependent manners. The adhesive activity of this protein is modulated upon cleavage by thrombin at the central part of the molecule, in the vicinity of the integrin-binding sequences. Although detailed structural characterization is crucial for further understanding of the regulatory mechanisms of the OPN functions, its intrinsically disordered property hampers in-depth conformational analyses. Here we report an NMR study of mouse OPN and its N-terminal thrombin-cleavage product to characterize intramolecular interaction of this molecule. Paramagnetic relaxation enhancement experiment revealed that OPN exhibits a long-range intramolecular interaction between the N- and C-terminal regions. Furthermore, our NMR data showed that anti-OPN antibody OPN1.2, whose reactivity is impaired by deletion or amino acid substitutions of the arginine-aspartate-glycine integrin-binding motif, binds the N-terminal side of the integrin-binding motifs suggesting the existence of intramolecular interaction. These data suggest that functional interactions of OPN with integrins and the other binding partners can be modulated by the intramolecular interactions. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20152802     DOI: 10.1016/j.bbrc.2010.02.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Post-translational modification of osteopontin: effects on in vitro hydroxyapatite formation and growth.

Authors:  Adele L Boskey; Brian Christensen; Hayat Taleb; Esben S Sørensen
Journal:  Biochem Biophys Res Commun       Date:  2012-02-10       Impact factor: 3.575

2.  Dynamic footprint of sequestration in the molecular fluctuations of osteopontin.

Authors:  S Lenton; T Seydel; T Nylander; C Holt; M Härtlein; S Teixeira; G Zaccai
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

3.  Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1.

Authors:  Norihisa Nishimichi; Hiromi Hayashita-Kinoh; Chun Chen; Haruo Matsuda; Dean Sheppard; Yasuyuki Yokosaki
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

4.  C-terminal modification of osteopontin inhibits interaction with the αVβ3-integrin.

Authors:  Brian Christensen; Eva Kläning; Mette S Nielsen; Mikkel H Andersen; Esben S Sørensen
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

Review 5.  Osteopontin in autoimmune disorders: current knowledge and future perspective.

Authors:  Canhua Xu; Yaohong Wu; Ning Liu
Journal:  Inflammopharmacology       Date:  2022-03-02       Impact factor: 5.093

Review 6.  NMR of Macromolecular Assemblies and Machines at 1 GHz and Beyond: New Transformative Opportunities for Molecular Structural Biology.

Authors:  Caitlin M Quinn; Mingzhang Wang; Tatyana Polenova
Journal:  Methods Mol Biol       Date:  2018

Review 7.  Osteopontin in Immune-mediated Diseases.

Authors:  S R Rittling; R Singh
Journal:  J Dent Res       Date:  2015-09-04       Impact factor: 6.116

8.  Structural Constraint of Osteopontin Facilitates Efficient Binding to CD44.

Authors:  Gulimirerouzi Fnu; Palak Agrawal; Gopal C Kundu; Georg F Weber
Journal:  Biomolecules       Date:  2021-05-30

9.  Phosphorylated Osteopontin Secreted from Cancer Cells Induces Cancer Cell Motility.

Authors:  Yoshinobu Kariya; Midori Oyama; Yukiko Kariya; Yasuhiro Hashimoto
Journal:  Biomolecules       Date:  2021-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.